Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04336852 · ClinicalTrials.gov registry record · NA
Development of a Clinically-relevant Test for Assessment of Cerebral Vascular Function
A NA study, sponsored by University of Illinois at Chicago.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT04336852 is a NA study that was terminated before completion, run by University of Illinois at Chicago. The registered enrollment target is 2 participants.
The verdict
NCT04336852, a NA study, was terminated before completion, sponsored by University of Illinois at Chicago.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The goal of this study is to develop a test of cerebral vessel function by inducing a reactive hyperemia that will elicit a rapid and profound increase in cerebral vessel shear stress. The results of this project may lead to development of a test with prognostic/predictive utility for individual risk assessment of a future cerebrovascular event/disease. This information will be of vital importance to the medical community in regards to cerebrovascular health in aging individuals, and testing of interventions and therapies that may ameliorate these effects.
Interventions
- PROCEDURE Flow mediated dilation (brachial and femoral arteries)
- PROCEDURE Cerebral vascular reactivity to carbon dioxide (CO2)
- PROCEDURE Cerebral vascular function test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2018-09-14 |
| Est. Completion | 2023-05-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04336852
The ClinicalTrials.gov registry entry for NCT04336852 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Flow mediated dilation (brachial and femoral arteries) is the first listed.
NCT04336852 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04336852 about?
NCT04336852 is a clinical study titled "Development of a Clinically-relevant Test for Assessment of Cerebral Vascular Function". The goal of this study is to develop a test of cerebral vessel function by inducing a reactive hyperemia that will elicit a rapid and profound increase in cerebral vessel shear stress. The results of this project may lead to development of a test with prognostic/predictive utility for individual ris...
What is the current status of trial NCT04336852?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2018-09-14. Estimated completion is 2023-05-12.
What interventions are being tested in trial NCT04336852?
The interventions under investigation include: Flow mediated dilation (brachial and femoral arteries) (PROCEDURE), Cerebral vascular reactivity to carbon dioxide (CO2) (PROCEDURE), Cerebral vascular function test (PROCEDURE).
Who is sponsoring clinical trial NCT04336852?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.